Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 3546 entries
View as:

Economic Analyses of the REDUCE Trial

Phase: N/A Priority: Normal
NCT ID: NCT01337258 Org: User:
Start: 01/31/10 End: 07/31/10 Due: 07/31/11

Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04428333 Org: User:
Start: 08/12/20 End: 09/19/23 Due: 09/19/24

Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT06372496 Org: User:
Start: 04/16/24 End: 03/11/26 Due: 03/11/27

To Investigate the Clinical Efficacy of an Experimental Toothpaste

Phase: N/A Priority: Normal
NCT ID: NCT01079910 Org: User:
Start: 12/09/09 End: 12/10/09 Due: 12/10/10

A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)

Phase: N/A Priority: Normal
NCT ID: NCT00382993 Org: User:
Start: 12/31/06 End: 11/30/07 Due: 11/30/08

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Phase: N/A Priority: Normal
NCT ID: NCT01248884 Org: User:
Start: 12/09/10 End: 01/05/12 Due: 01/05/13

Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00355082 Org: User:
Start: 05/31/06 End: 11/30/08 Due: 11/30/09

A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01017952 Org: User:
Start: 09/25/09 End: 10/17/11 Due: 10/17/12

Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults

Phase: N/A Priority: Normal
NCT ID: NCT00968526 Org: User:
Start: 09/08/09 End: 09/23/10 Due: 09/23/11

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Phase: N/A Priority: Normal
NCT ID: NCT01681992 Org: User:
Start: 10/10/12 End: 08/18/15 Due: 08/18/16

Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT01730378 Org: User:
Start: 12/05/12 End: 12/17/13 Due: 12/17/14

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01725126 Org: User:
Start: 02/10/13 End: 09/12/13 Due: 09/12/14

Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197

Phase: N/A Priority: Normal
NCT ID: NCT00263653 Org: User:
Start: 03/31/05 End: 09/30/05 Due: 09/30/06

Assess GSK Biologicals' MMR Vaccine (Priorix) When Given to Healthy Children at the Age of 12 to 18 Months in Singapore.

Phase: N/A Priority: Normal
NCT ID: NCT00388440 Org: User:
Start: 11/30/00 End: 04/30/01 Due: 04/30/02

Bioequivalence Study of Montelukast 10 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01943942 Org: User:
Start: 05/16/10 End: 05/26/10 Due: 05/26/11

Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00996996 Org: User:
Start: 06/30/96 End: 10/31/11 Due: 10/31/12

Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01458054 Org: User:
Start: 09/27/11 End: 11/28/11 Due: 11/28/12

A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02567708 Org: User:
Start: 10/01/15 End: 09/28/16 Due: 09/28/17

A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02233803 Org: User:
Start: 11/14/14 End: 12/11/15 Due: 12/11/16

Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P)

Phase: N/A Priority: Normal
NCT ID: NCT05682326 Org: User:
Start: 09/06/23 End: 03/17/25 Due: 03/17/26

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Phase: N/A Priority: Normal
NCT ID: NCT01358825 Org: User:
Start: 05/30/11 End: 07/15/11 Due: 07/15/12

Immunization of Children Previously Primed With GSK Pneumococcal Vaccine GSK1024850A and of Unprimed Children in Mali

Phase: N/A Priority: Normal
NCT ID: NCT00985465 Org: User:
Start: 11/12/09 End: 07/26/10 Due: 07/26/11

Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)

Phase: N/A Priority: Normal
NCT ID: NCT01381432 Org: User:
Start: 12/31/04 End: 05/31/11 Due: 05/31/12

12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD)

Phase: N/A Priority: Normal
NCT ID: NCT01362348 Org: User:
Start: 07/07/11 End: 04/16/12 Due: 04/16/13

Nicotine Lozenge Bioequivalence Study

Phase: N/A Priority: Normal
NCT ID: NCT01536704 Org: User:
Start: 07/31/11 End: 08/31/11 Due: 08/31/12